L. Bergstrand

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

Göran Walldius, Uno Erikson, Anders Olsson et al. · The American Journal of Cardiology · 1994 · 250 citations

Medicine, Cardiology, Preventive Medicine +11

Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction

Ann Samnegård, Angela Silveira, Pia Lundman et al. · Journal of Internal Medicine · 2005 · 126 citations · Full text

Medicine, Cardiology, Genetics +17

Human Evidence That the Cystatin C Gene Is Implicated in Focal Progression of Coronary Artery Disease

Per Eriksson, Hiroyuki Deguchi, Ann Samnegård et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 101 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Lowering of HDL _2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia

Jan Johansson, Anders Olsson, L. Bergstrand et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1995 · 81 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Tortuosity and atherosclerosis in the femoral artery: What is cause and what is effect?

Örjan Smedby, L. Bergstrand · Annals of Biomedical Engineering · 1996 · 73 citations

Veterinary Medicine, Cardiology, Surgery +11